Peregrine Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.3M | 204k | 11.38 |
| 2024-06-30 | $1.9M | 260k | 7.14 |
| 2024-03-31 | $1.6M | 240k | 6.70 |
| 2023-12-31 | $1.6M | 254k | 6.50 |
| 2023-09-30 | $5.0M | 532k | 9.44 |
| 2023-06-30 | $7.8M | 561k | 13.97 |
| 2023-03-31 | $11M | 594k | 18.76 |
| 2022-12-31 | $8.5M | 621k | 13.77 |
| 2022-09-30 | $0 | 630k | 0.00 |
| 2022-06-30 | $9.6M | 631k | 15.28 |
| 2022-03-31 | $13M | 659k | 20.37 |
| 2021-12-31 | $0 | 642k | 0.00 |
| 2021-09-30 | $0 | 209k | 0.00 |
| 2021-06-30 | $4.9M | 191k | 25.65 |
| 2021-03-31 | $3.5M | 192k | 18.24 |
| 2020-12-31 | $2.5M | 220k | 11.54 |
| 2020-09-30 | $1.6M | 216k | 7.63 |
| 2020-06-30 | $0 | 218k | 0.00 |
| 2020-03-31 | $978k | 191k | 5.12 |
| 2019-12-31 | $1.5M | 200k | 7.67 |
| 2019-09-30 | $931k | 175k | 5.31 |
| 2019-06-30 | $941k | 168k | 5.61 |
| 2019-03-31 | $709k | 167k | 4.24 |
| 2018-12-31 | $698k | 170k | 4.10 |
| 2018-09-30 | $1.1M | 155k | 6.85 |
| 2018-06-30 | $504k | 130k | 3.89 |
| 2018-03-31 | $96k | 33k | 2.94 |